Pharma and cosmetics multinational selects BioAscent as central hub for storage and logistics of extensive plant natural extracts collection
BioAscent Discovery, announces a new collaboration with pharmaceutical and cosmetics multinational, Pierre Fabre, as part of an open innovation initiative promoting the use of natural products in life sciences. Pierre Fabre’s library of ca. 15,000 plant extracts is the largest private collection of its type in the world. BioAscent’s state-of-the-art compound management and logistics facility is ideally placed to share out such an extract...
EATRIS (European Infrastructure for Translational Medicine) has today announced a partnership with Dutch Arthritis Foundation Reumafonds, to advance translational research for rheumatic disorders.
The announcement follows a successful pilot, which saw the two organisations join under the EATRIS Inside model, which offers funders access to translational research expertise and facilities to support the optimisation of their research portfolio. As part of the new collaboration, EATRIS will support Reumafonds with their projects that seek to translate new scientific insights into promising medicines and diagnostics for a wide range of...
Veolia Water Technologies has released a new video showing how their ultrapure water technology is helping cutting edge research at the National Graphene Institute.
The video includes material provided by The University of Manchester, in particular a fascinating introduction to graphene, the most exciting material of the 21st century, its almost limitless potential and the amazing research facility that is the National Graphene Institute. Graphene is only a single molecule thick and research at this level requires water of ultimate purity - well in advance of the current highest standards for semiconductor...
Themis Bioscience GmbH, a leading company developing prophylactic vaccines against emerging tropical infectious diseases, today announced the appointment of two new leadership members, Dr. Philippe Dro and Dr. Christian Mandl.
The appointment follows in the wake of the successful completion of a phase I clinical trial of the company's Chikungunya vaccine, and so Themis is heading for hot times – and is growing steadily. Dr. Philippe Dro, a renowned life science entrepreneur will join the Board of Directors. The Scientific Advisory Board of Themis Bioscience will in the future benefit from the outstanding experience of Dr. Christian Mandl as chai....
The ideal solution for scaling studies and low volume ultra- and diafiltration operations
Sartorius Stedim Biotech (SSB), an international leading supplier for the biopharmaceutical industry, announces the launch of SARTOFLOW® Smart, the smart and easy benchtop crossflow system for optimized ultra- and diafiltration applications. It can ideally be used in many downstream processes, such as purification of vaccines, monoclonal antibodies and recombinant proteins. The system is suitable for flexible use in laboratory...
Avere FXT Series Edge Filers and Flash Capabilities Vault Space Data onto the AWS Cloud
Avere Systems, a leading provider of enterprise storage for the hybrid cloud, today announced that NASA has selected Avere to help consolidate legacy storage and move many of its datasets to the Amazon Web Services (AWS) Cloud. Avere will be supporting the Ames Research Center, NASA’s Silicon-Valley field center, which has led NASA in conducting world-class research and development. Breakthrough research conducted at the...
AMSBIO announces the launch of the Oris™ 3D Embedded Invasion Assay – a unique product offering quantifiable real-time analysis of cell invasion.
This new cell invasion assay is designed to enable cell movement through an extracellular matrix (ECM) in 3-Dimensions, thereby getting you as close as possible to an in vivo experiment using in vitro conditions. The invasion capacity of tumor cells is of particular concern in cancer research, and is a first step to metastasis, the deadliest aspect of the disease. Traditionally, cell invasion assays are performed by seeding cells in a...
New improved antibody oligonucleotide conjugation kit
Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, today announced the launch of Thunder-Link® PLUS, a new and improved version of the original Thunder-Link kit, enabling even faster and more efficient oligonucleotide conjugation. The new kit offers all of the advantages of the original Thunder-Link technology, but now also works with antibody fragments and small proteins...
Magritek, a leading provider of compact NMR and MRI instruments, report on the use of their Spinsolve Benchtop NMR spectrometer in the Chemistry Department of Samford University located in Birmingham, Alabama.
It is being applied in research in the areas of organic synthesis, reaction methodology and medicinal chemistry. Dr Paul Wiget is an assistant professor of chemistry at Samford University in Birmingham, Alabama. He first became interested in the Spinsolve instrument when he began interviewing for his current position knowing that his research interests would require a work-around for the lack of a local high-field NMR. Spinsolve, as a...
Plasma cells play a key role in our immune system.
Now scientists at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria, and at the Walter and Eliza Hall Institute (WEHI) in Melbourne, Australia, succeeded in characterizing a central regulator of plasma cell function. The results of both teams are published in two back-to-back papers in "Nature Immunology" today. Our environment teems with microorganisms and viruses that are potentially...
A Cancer Research facility in Hertfordshire is among a growing contingent of clinical trial sites that have adopted asepticSU™ single use fluid path technology from Watson-Marlow Fluid Technology Group.
Used in conjunction with two Flexicon FP50 automated filling and stoppering machines, asepticSU™ has helped the Biotherapeutics Development Unit (BDU) at South Mimms to eliminate the need for cleaning validation and simplify traceability of applied product contact components. The BDU is a modern, MHRA licensed, fully GMP-compliant, 2000 m² facility that is engaged in the process development and production of novel Investigational Medicinal Products (IMPs) for...
Deben, a leading provider of in-situ testing stages together with innovative accessories and components for electron microscopy, reports on the use of a Microtest tensile stage in the Institute of Photonics & Quantum Sciences at Heriot-Watt University, Edinburgh.
It is being used for stress analysis studies of ceramics and engineering plastics. Dr Peter Schemmel is a postdoctoral researcher in Applied Photonics at Heriot-Watt University. He is part of the team at the Institute of Photonics and Quantum Sciences in a group which focuses on stress analysis in ceramics and engineering plastics. They are particularly interested in ceramic thermal barrier coatings used on aeroplane engine turbine blades or...
Strategic partnership creates a world leading CDMO offer to supply AAV-based viral vectors, an increasingly attractive therapeutic platform for gene therapy
Novasep, a leading supplier of services and technologies for the life sciences industry, and Advanced Biotherapeutics Consulting (ABC), a service provider that leverages the expertise of the Nantes Gene Therapy Institute led by Philippe Moullier, MD, PhD, today announce they have entered into a CDMO (Contract Development Manufacturing Organization) partnership. This partnership enables the companies to provide their respective...
The Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, a Pennsylvania non-profit corporation, is proud to announce its 2016 Pittsburgh Conference Memorial National College Grant (PCMNCG) recipients.
The maximum funding available this year for each grant is $10,000. The money is awarded to the science departments of colleges with less than 5,000 full-time students for the purchase of scientific equipment, audio-visual or other teaching aids, and/or library materials for use in the teaching of science at the undergraduate level. This year’s awardees are as follows...
Centauri Therapeutics Ltd, a biotechnology company focused on the treatment of infectious diseases, announced today that it has acquired the Alphamer technology for drug discovery and development from Altermune Technologies LLC.
Centauri Therapeutics acquired full rights to patents, proprietary compounds, know-how and collaboration/licence agreements from Altermune in exchange for an undisclosed fee. The company has also announced that it has appointed Dr Clive Dix as Chairman and secured the first tranche of a £3M raise to develop its first lead candidate. The funding will be used to develop its first lead Alphamers against anti-microbial resistant...
This upcoming webinar hosted by Oxford Global will provide an insight on the Advances In Inhaled Insulin Research on Wednesday 17th February 2016 | 3 pm GmT.
Inhalable insulin research represents a very exciting area of the inhalation drug delivery market. Inhaled insulin has evoked a lot of interest recently and shows a great promise in treating diabetes. Oxford Global’s free webinar offer attendees the unique opportunity to hear recent advancements in inhalable insulin research as well as aerosol technology. Through the interactive Q&A session, attendees will also...
Synbiosis,a long-established, expert manufacturer of automated microbiological systems, is delighted to announce a new paper entitled, ‘Evaluation of heterotrophic plate and chromogenic agar colony counting in water quality laboratories’ has been published in the peer-reviewed journal, Methods X.
The paper details how scientists at the Australian Water Quality Centre (AWQC) have for the first time independently validated that results from the ProtoCOL 3 automated colony counter are as accurate as manual colony counting. The article describes how microbiologists at AWCQ, a leading NATA (National Association of Testing Authorities) accredited water testing laboratory in Adelaide, Australia cultured microorganisms isolated from...
The stem cell disease model specialists recruit leading biologist, Prof Xianmin Zeng as Chief Scientific Officer
Axol Bioscience, a biotechnology company, specialising in the use of stem cell technology to manufacture disease relevant cell based assay systems to the drug discovery industry, today announced Prof Xianmin Zeng, PhD as Chief Scientific Officer (CSO). Prof Zeng is an accomplished biologist with over 15 years of academic expertise in the development of stem cell technologies and its applications. A biotech entrepreneur with an extensive...
Cancers evolve over time in patterns governed by the same natural laws that drive physical and chemical processes as diverse as the flow of rivers or the brightness of stars, a new study reports.
Researchers believe that in the future, they could predict how a cancer will grow and develop by applying natural laws to single genetic snapshots taken from a cancer. The intriguing research raises the possibility that doctors could take clinical decisions on how an individual patient’s cancer will change, and what treatments should be used, by applying mathematical formulas to tumour biopsies. Scientists at The Institute of...
In preparation for the trial Myeloma UK worked closely with Takeda initiating a first-of-its kind pilot, by going jointly to NICE to seek scientific advice on both TOURMALINE-MM1 and MUK eight
This is the first time a medical research charity and a pharmaceutical company have gone jointly to NICE Scientific Advice. Myeloma UK announces that MUK eight, a Phase II trial of the oral proteasome inhibitor, ixazomib, is now open for recruitment. MUK eight is a randomised Phase II trial comparing the novel oral proteasome inhibitor ixazomib in combination with cyclophosphamide and dexamethasone, against a combination of cyclophosphamide and dexamethasone in relapsed and/or refractory myeloma patients. This is the eighth trial to be set up...
Synpromics Ltd, a leading synthetic biology company, and The Cell Therapy Catapult, the UK organisation accelerating the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announce the launch of a collaboration to remove a major barrier to the development of the cell and gene therapy industry by reducing the cost and increasing the scale and efficiency of viral vector manufacturing.
The collaboration will use Synpromics' synthetic promoter design technology, and the Cell Therapy Catapult's flexible manufacturing platform to create stable producer cell lines for the high titre and large scale manufacture of viral vectors. The work will be part funded by a £2m grant from Innovate UK, the UK’s innovation agency. Viral vectors are a crucial tool needed to modify patient’s cells to create a therapeutic effect...
BioAscent Discovery, announces a new collaboration with pharmaceutical and cosmetics multinational, Pierre Fabre, as part of an open innovation initiative promoting the use of natural products in life sciences. Pierre Fabre’s library of ca. 15,000 plant extracts is the largest private collection of its type in the world. BioAscent’s state-of-the-art compound management and logistics facility is ideally placed to share out such an extract...
The announcement follows a successful pilot, which saw the two organisations join under the EATRIS Inside model, which offers funders access to translational research expertise and facilities to support the optimisation of their research portfolio. 
The video includes material provided by The University of Manchester, in particular a fascinating introduction to graphene, the most exciting material of the 21
The appointment follows in the wake of the successful completion of a phase I clinical trial of the company's Chikungunya vaccine, and so Themis is heading for hot times – and is growing steadily. Dr. Philippe Dro, a renowned life science entrepreneur will join the Board of Directors. The Scientific Advisory Board of Themis Bioscience will in the future benefit from the outstanding experience of Dr. Christian Mandl as chai....
Sartorius Stedim Biotech (SSB), an international leading supplier for the biopharmaceutical industry, announces the launch of SARTOFLOW® Smart, the smart and easy benchtop crossflow system for optimized ultra- and diafiltration applications. It can ideally be used in many downstream processes, such as purification of vaccines, monoclonal antibodies and recombinant proteins. The system is suitable for flexible use in laboratory...
Avere Systems
This new cell invasion assay is designed to enable cell movement through an extracellular matrix (ECM) in 3-Dimensions, thereby getting you as close as possible to an in vivo experiment using in vitro conditions. 
Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, today announced the launch of Thunder-Link® PLUS, a new and improved version of the original Thunder-Link kit, enabling even faster and more efficient oligonucleotide conjugation. The new kit offers all of the advantages of the original Thunder-Link technology, but now also works with antibody fragments and small proteins...
It is being applied in research in the areas of organic synthesis, reaction methodology and medicinal chemistry. 
Now scientists at the Research Institute of Molecular Pathology (IMP) in Vienna, Austria, and at the Walter and Eliza Hall Institute (WEHI) in Melbourne, Australia, succeeded in characterizing a central regulator of plasma cell function. 
Used in conjunction with two Flexicon FP50 automated filling and stoppering machines, asepticSU™ has helped the Biotherapeutics Development Unit (BDU) at South Mimms to eliminate the need for cleaning validation and simplify traceability of applied product contact components. The BDU is a modern, MHRA licensed, fully GMP-compliant, 2000 m² facility that is engaged in the process development and production of novel Investigational Medicinal Products (IMPs) for...
It is being used for stress analysis studies of ceramics and engineering plastics. 
Novasep, a leading supplier of services and technologies for the life sciences industry, and Advanced Biotherapeutics Consulting (ABC), a service provider that leverages the expertise of the Nantes Gene Therapy Institute led by Philippe Moullier, MD, PhD, today announce they have entered into a CDMO (Contract Development Manufacturing Organization) partnership. This partnership enables the companies to provide their respective...
The maximum funding available this year for each grant is $10,000. The money is awarded to the science departments of colleges with less than 5,000 full-time students for the purchase of scientific equipment, audio-visual or other teaching aids, and/or library materials for use in the teaching of science at the undergraduate level. This year’s awardees are as follows...
Centauri Therapeutics acquired full rights to patents, proprietary compounds, know-how and collaboration/licence agreements from Altermune in exchange for an undisclosed fee. 
Inhalable insulin research represents a very exciting area of the inhalation drug delivery market. Inhaled insulin has evoked a lot of interest recently and shows a great promise in treating diabetes. Oxford Global’s free webinar offer attendees the unique opportunity to hear recent advancements in inhalable insulin research as well as aerosol technology. Through the interactive Q&A session, attendees will also...
The paper details how scientists at the Australian Water Quality Centre (AWQC) have for the first time independently validated that results from the ProtoCOL 3 automated colony counter are as accurate as manual colony counting. The article describes how microbiologists at AWCQ, a leading NATA (National Association of Testing Authorities) accredited water testing laboratory in Adelaide, Australia cultured microorganisms isolated from...
Axol Bioscience, a biotechnology company, specialising in the use of stem cell technology to manufacture disease relevant cell based assay systems to the drug discovery industry, today announced Prof Xianmin Zeng, PhD as Chief Scientific Officer (CSO). Prof Zeng is an accomplished biologist with over 15 years of academic expertise in the development of stem cell technologies and its applications. A biotech entrepreneur with an extensive...
Researchers believe that in the future, they could predict how a cancer will grow and develop by applying natural laws to single genetic snapshots taken from a cancer. 
This is the first time a medical research charity and a pharmaceutical company have gone jointly to NICE Scientific Advice. Myeloma UK announces that MUK eight, a Phase II trial of the oral proteasome inhibitor, ixazomib, is now open for recruitment. MUK eight is a randomised Phase II trial comparing the novel oral proteasome inhibitor ixazomib in combination with cyclophosphamide and dexamethasone, against a combination of cyclophosphamide and dexamethasone in relapsed and/or refractory myeloma patients. This is the eighth trial to be set up...
The collaboration will use Synpromics' synthetic promoter design technology, and the Cell Therapy Catapult's flexible manufacturing platform to create stable producer cell lines for the high titre and large scale manufacture of viral vectors. The work will be part funded by a £2m grant from Innovate UK, the UK’s innovation agency. 